优服务、兴产业，三方共建“长效赋能”新支点

Core Insights - The collaboration between the Nanjing Medical Device Industrial Park Management Office, Jiangsu Provincial Drug Administration Review Center, and Nanjing Market Supervision Administration aims to enhance service quality and empower the medical device industry through regular joint service activities [1][3]. Group 1: Service Mechanism - A "consultation service co-construction point" has been officially launched, establishing a direct service channel from provincial resources to park enterprises, thereby creating a new service model for long-term empowerment in the medical device industry [3]. - The initiative is expected to accelerate innovation within the medical device sector by providing targeted support and resources [3]. Group 2: Direct Engagement - The Jiangsu Provincial Drug Administration Review Center's leadership engaged directly with over 20 enterprise representatives to address 41 specific issues related to clinical evaluation, biological evaluation, performance indicators, and product naming, providing immediate assistance [6]. - On-site visits to innovative companies such as Nanjing Ruid Medical Technology Co., Ltd. and Puling Bio (Nanjing) Co., Ltd. were conducted to identify and resolve challenges in product classification, clinical research, and innovation review [7]. Group 3: Training and Development - A specialized training session was held for 65 enterprise representatives, focusing on the latest developments in the medical device industry, including updates to the 2025 edition of the Chinese Pharmacopoeia and key points for the registration of Class I medical devices [8]. - The training aimed to enhance the professional capabilities of enterprises, ensuring they meet regulatory requirements and fostering sustainable industry growth [8]. Group 4: Future Directions - The three parties plan to continue strengthening their partnership, integrating party building with business operations, and optimizing long-term service models to support enterprise innovation and stable growth in the medical device industry [8].